Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PMPA prodrug selected as clinical candidate

Feb. 3, 1997

Gilead selects GS-930 prodrug for further evaluation

Feb. 3, 1997

Aronex describes anti-HCMV compound

Feb. 3, 1997

Genotypic analysis of patients treated with adefovir dipivoxil

Jan. 31, 1997

Cel-Sci presents results with heteroconjugate technology for HIV vaccine development

Jan. 31, 1997

NCI discloses anti-HIV agent with novel mechanism of action

Jan. 31, 1997

Abbott develops protease inhibitor for combination therapy

Jan. 31, 1997

Thalidomide: Forty years later

Jan. 30, 1997

Cidofovir highlighted at retroviral conference

Jan. 30, 1997

Pilot trial of folic acid in stroke patients

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...